Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
AstraZeneca
Johnson and Johnson
McKesson
Harvard Business School

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

BAXTER Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for BAXTER

Drugs and US Patents for BAXTER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp PROTOPAM CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 014134-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-004 Jul 26, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare CEFTRIAXONE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 065224-002 Aug 23, 2005 RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare CARDIOPLEGIC IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium chloride SOLUTION;PERFUSION, CARDIAC 075323-001 Apr 21, 2000 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BAXTER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare FORANE isoflurane LIQUID;INHALATION 017624-001 Approved Prior to Jan 1, 1982 3,535,388 ⤷  Free Forever Trial
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-003 Oct 10, 1992 5,696,172 ⤷  Free Forever Trial
Baxter Hlthcare ETHRANE enflurane LIQUID;INHALATION 017087-001 Approved Prior to Jan 1, 1982 3,469,011 ⤷  Free Forever Trial
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-007 May 28, 2003 6,310,094*PED ⤷  Free Forever Trial
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 5,213,804 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for BAXTER drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Inhalation 99.90% ➤ Subscribe 2008-09-11
➤ Subscribe Injection 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags ➤ Subscribe 2014-01-31

Supplementary Protection Certificates for BAXTER Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0484186 1190033-9 Sweden ⤷  Free Forever Trial PRODUCT NAME: 4-AMINOPYRIDIN ELLER ETT SALT DAERAV; REG. NO/DATE: EU/1/11/699/001 20110720
1532149 8/2012 Austria ⤷  Free Forever Trial PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION UND DESSEN SALZE, INSBES. LINAGLIPTIN; REGISTRATION NO/DATE: EU/1/11/707/001-011 (MITTEILUNG) 20110830
1273292 C01273292/01 Switzerland ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009
1534313 CA 2015 00072 Denmark ⤷  Free Forever Trial PRODUCT NAME: OKULAER SKYLLEVAESKE OMFATTENDE PHENYLEPHRIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER HYDROCHLORID OG KETOROLAC ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER KETOROLACTROMETAMOL; REG. NO/DATE: EU/1/15/1018 20150730
2404919 1690018-5 Sweden ⤷  Free Forever Trial PRODUCT NAME: 3-6-1-(2,2-DIFLUORO-1,3-BENZODIOXOL-5- YL)CYCLOPROPANECARBONYLAMINO-3-METHYLPYRIDIN-2-YLBENZOIC ACID, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR AN ESTER THEREOF.; REG. NO/DATE: EU/1/15/1059 20151124
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Boehringer Ingelheim
Moodys
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.